K Health will work with Mayo Clinic to integrate its tools with the Rochester, Minn.-based health system’s clinical data analytics platform. Mayo launched its Clinical Data Analytics Platform in January as part of its venture to identify drug targets and biomarkers to advance drug development to cure complex diseases.
In addition to its collaboration with Mayo Clinic, K Health also closed a $42 million series D financing round to expand its telemedicine offering, which provides consultations that begin with an AI analysis of patients’ symptoms before transferring them to an on-call physician for diagnosis and any necessary prescriptions.
More articles on data analytics:
Google, Harvard update COVID-19 forecasting model: 4 details
Cleveland halts COVID-19 data update because of spike in new cases
Change Healthcare launches social determinants of health analytics resource: 3 notes
